Berenberg Bank Reiterates “Buy” Rating for Abcam (ABC)
ABC has been the topic of several other research reports. JPMorgan Chase & Co. reiterated a neutral rating on shares of Abcam in a research report on Wednesday, January 2nd. Peel Hunt reissued a hold rating on shares of Abcam in a research note on Thursday, December 6th. Finally, Numis Securities reissued a hold rating on shares of Abcam in a research note on Tuesday, September 11th.
Shares of LON ABC opened at GBX 1,216 ($15.89) on Tuesday. Abcam has a 1 year low of GBX 9.73 ($0.13) and a 1 year high of GBX 1,290 ($16.86).
Abcam Company Profile
Abcam plc, together with its subsidiaries, produces and distributes research-grade antibodies and associated protein research tools worldwide. The company primarily offers primary and secondary antibodies; ELISA, matched antibody pairs and multiplex immunoassays; cell and tissue imaging tools; cellular and biochemical assays; proteins and peptides; proteomics tools; agonists, antagonists, activators, and inhibitors; lysates; and multiplex miRNA assays.
See Also: Treasury Bonds
Receive News & Ratings for Abcam Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abcam and related companies with MarketBeat.com's FREE daily email newsletter.